Skip to main content

Innolith makes breakthrough in vehicle batteries

| News

Innolith makes breakthrough in vehicle batteries

04.04.2019

Energy company Innolith has developed a new type of battery that gives electric vehicles a range of 1,000km. The innovation has now been registered for a patent and will be launched on the market via an initial pilot production.

Innolith Battery

Basel energy company Innolith has developed a battery innovation at its German laboratory in Bruchsal. According to a press release, this rechargeable battery is capable of powering an electric vehicle for over 1,000km on a single charge. The battery avoids exotic and expensive materials and therefore radically reduces overall cost.

In addition to its range and cost advantages, the new battery is also safer. It is the first non-flammable lithium-based battery for use in electric vehicles. Rather than conventional flammable organic electrolytes, the Innolith battery uses a non-flammable inorganic electrolyte.

A patent application has been filed for this battery technology and Innolith is maintaining commercial confidentiality on the cell chemistry mechanism. The chemistry used in this battery has reportedly been proven to operate for more than 55,000 full depth discharge cycles, which is between 10 and 100 times the maximum number of cycles of existing lithium ion batteries in use today.

Innolith will be bringing its Energy Battery to market via an initial pilot production in Germany soon. The aim is to later conclude licensing partnerships with battery manufacturers. BaselArea.swiss supported Innolith in 2018 with the opening of the global headquarters in Basel.

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

biGENIUS receives 2 million euros for new cloud product

Software company biGENIUS, based in the Basel Area, has secured financing of 2 million euros. This funding was granted following...
Read More

Opterion Health secures investment of 6.5 million Swiss francs

Opterion Health has raised a total of 6.5 million Swiss francs as part of a financing round. The company, which...
Read More

TOLREMO receives 39 million US dollars in investments

TOLREMO Therapeutics has concluded a series A funding round with 39 million US dollars. The biotech company based in Basel...
Read More

Mazars opens tenth Swiss office in Basel

Mazars is now also present in Basel with a subsidiary as of September 1. This is the tenth Swiss location...
Read More

Medtech in Switzerland – bringing together traditional skills and hightech industry

How the intersection of traditional and novel skillsets in the Jura area is propelling Switzerland into a new era of...
Read More

Fondation Botnar supporting further research into pediatric health

The Basel-based Botnar Research Centre for Child Health has received a further donation of 50 million Swiss francs from the...
Read More

Do you have a question? We'd like to hear from you.